Standout Papers
- Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood (1996)
- Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma (1999)
- Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. (1994)
- Stimulation of Human Anti-Viral CD8+ Cytolytic T Lymphocytes by Dendritic Cells (1995)
- Dendritic Cells as Immunogens for Human CTL Responses (1997)
Citation Impact
Citing Papers
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
2004 StandoutScience
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins
2001
Hallmarks of Cancer: The Next Generation
2011 Standout
Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability
2000
Dendritic cells as therapeutic vaccines against cancer
2005
Dendritic cells crossprime allo-specific self-restricted CD4+ T cells after coculture with dead allogeneic cells
2002 StandoutNobel
Dendritic cells: On the move from bench to bedside
2001
Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicability
1996
Paraneoplastic neurological degenerations: keys to tumour immunity
2004
Dendritic Cells as Vectors for Therapy
2001
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
2003
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity
2001
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Mature Dendritic Cells Respond to SDF-1, but not to Several β-Chemokines
1998
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
Developmental regulation of MHC class II transport in mouse dendritic cells
1997 StandoutNatureNobel
Carbonic anhydrase–related protein VIII: Autoantigen in paraneoplastic cerebellar degeneration
2004
Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG
2003
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
2001
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Immune surveillance of tumors
2007
Origin, maturation and antigen presenting function of dendritic cells
1997
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals
1999 StandoutNobel
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses
2009 StandoutNobel
Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor
1997
Immunomodulatory treatment trial for paraneoplastic neurologicaldisorders
2004
Mouse and human dendritic cell subtypes
2002 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Dendritic cells in the T‐cell areas of lymphoid organs
1997 StandoutNobel
Epitope affinity for MHC class I determines helper requirement for CTL priming
2000 StandoutNobel
Active Immunization of Humans with Dendritic Cells
2000
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
2011 StandoutNobel
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
1998 StandoutNature
Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo
1999 StandoutNobel
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Current therapies for paraneoplastic neurologic syndromes
2003
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Preparation of Clinical‐Grade Recombinant Canarypox–Human Immunodeficiency Virus Vaccine–Loaded Human Dendritic Cells
2002 StandoutNobel
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Dendritic cell immunotherapy: mapping the way
2004
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
2003
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
1998
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T‐lymphocytes and preserved MHC class I antigen expression
2008
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
2002
Origin of dendritic cells in peripheral lymphoid organs of mice
2007
Autoimmunity to Gephyrin in Stiff-Man Syndrome
2000
Cancer immunotherapy with mRNA‐transfected dendritic cells
2004
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Anti-Yo Positive Paraneoplastic Cerebellar Degeneration Associated with Ovarian Carcinoma: Case Report and Review of the Literature
1999
Programmed Cell Death (Apoptosis) in Human Monocytes Infected by Influenza A Virus
1994
The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival
1999
Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood
2001
Dendritic cells, loaded with recombinant bacteria expressing tumor antigens, induce a protective tumor-specific response.
2001
Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells
2000
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
2003 StandoutNobel
New Purkinje cell antibody (PCA-2): Marker of lung cancer-related neurological autoimmunity
2000
Dendritic Cell Vaccines for Cancer Immunotherapy
1999
Recent Developments in Cancer Vaccines
2011
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
1997 StandoutNobel
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
2007
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells
1997
The Three Es of Cancer Immunoediting
2004 Standout
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.
2003
Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells.
2000
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.
2001 StandoutNobel
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
2001 StandoutNobel
In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas
1999
Production of IL-12 by Human Monocyte-Derived Dendritic Cells Is Optimal When the Stimulus Is Given at the Onset of Maturation, and Is Further Enhanced by IL-4
2001
Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA
1999
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
1997
Paraneoplastic Neurologic Disease Antigens: RNA-Binding Proteins and Signaling Proteins in Neuronal Degeneration
2001
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells
1997
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion
1999 StandoutNobel
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
2002
Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells
2000
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions
2001
The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli
2000 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
1995
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
1998
Opsonization of Apoptotic Cells by Autologous iC3b Facilitates Clearance by Immature Dendritic Cells, Down-regulates DR and CD86, and Up-regulates CC Chemokine Receptor 7
2002
Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
2002
Consequences of Cell Death
2000
Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells
2000 StandoutScienceNobel
Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production
2001
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors
1996 StandoutNobel
A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells
1997
Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes
1998
Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism
1999
Lipopolysaccharide or Whole Bacteria Block the Conversion of Inflammatory Monocytes into Dendritic Cells In Vivo
2003 StandoutNobel
NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo
2003
Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma
2003 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity
2001
Prostaglandin E2 and Tumor Necrosis Factor α Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production
1997
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
1997
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells
2004
Activation of influenza virus–specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity
2003
Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells
2002
Tolerogenic Dendritic Cells
2003 StandoutNobel
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors.
2000
EBI1/CCR7 Is a New Member of Dendritic Cell Chemokine Receptor That Is Up-Regulated upon Maturation
1998
Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
2000
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Antigen Presentation and T Cell Stimulation by Dendritic Cells
2002
Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
2001 StandoutNobel
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Immature Dendritic Cells Selectively Replicate Macrophagetropic (M-Tropic) Human Immunodeficiency Virus Type 1, while Mature Cells Efficiently Transmit both M- and T-Tropic Virus to T Cells
1998 StandoutNobel
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
2000
Trypanosoma cruziInfects Human Dendritic Cells and Prevents Their Maturation: Inhibition of Cytokines, HLA-DR, And Costimulatory Molecules
1999
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
2003 StandoutNobel
Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells
1997
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Armin Bender being referenced
The Distinctive Features of Influenza Virus Infection of Dendritic Cells
1998
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
1996 StandoutNobel
Tumor-specific killer cells in paraneoplastic cerebellar degeneration
1998
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
1994 StandoutNobel
Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival
2009
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
1999
Efficient Expression of the Tumor-Associated Antigen MAGE-3 in Human Dendritic Cells, Using an Avian Influenza Virus Vector
2000
Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides.
1990
Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses.
1995
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response
1997
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity.
1993
Role of Macrophage Cytokines in Influenza A Virus lnfections
1993
Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells
2000
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
2006
Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
2002
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones
2004
Intratumoral T-Cell Infiltrates and MHC Class I Expression in Patients with Stage IV Melanoma
2005